BioLineRx Ltd. (BLRX)
NASDAQ: BLRX
· Real-Time Price · USD
4.67
0.45 (10.66%)
At close: Jun 04, 2025, 3:59 PM
4.52
-3.21%
Pre-market: Jun 05, 2025, 07:49 AM EDT
10.66% (1D)
| Bid | 4.48 |
| Market Cap | 17.38M |
| Revenue (ttm) | 28.94M |
| Net Income (ttm) | -9.22M |
| EPS (ttm) | -6 |
| PE Ratio (ttm) | -0.78 |
| Forward PE | -16.42 |
| Analyst | Buy |
| Ask | 4.7 |
| Volume | 262,668 |
| Avg. Volume (20D) | 622,077 |
| Open | 4.13 |
| Previous Close | 4.22 |
| Day's Range | 4.00 - 4.73 |
| 52-Week Range | 2.30 - 35.60 |
| Beta | 0.86 |
About BLRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BLRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BLRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
BioLineRx has released their quartely earnings
on May 27, 2025:
5 days ago
+38.52%
BioLineRx shares are trading higher after the comp...
Unlock content with
Pro Subscription
4 months ago
-16.8%
BioLineRx shares are trading lower after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.
